SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis

• Robert T. Jacobs ,

  * E-mail: bob.jacobs@scynexis.com

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Bakela Nare,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Stephen A. Wring,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Matthew D. Orr,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Daitao Chen,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Jessica M. Sligar,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Matthew X. Jenks,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Robert A. Noe,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Tana S. Bowling,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Luke T. Mercer,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Cindy Rewerts,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Eric Gaukel,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Jennifer Owens,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Robin Parham,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Ryan Randolph,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Beth Beaudet,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Cyrus J. Bacchi,

  Affiliation Haskins Laboratory, Pace University, New York, New York, United States of America

  ⨯
• Nigel Yarlett,

  Affiliation Haskins Laboratory, Pace University, New York, New York, United States of America

  ⨯
• Jacob J. Plattner,

  Affiliation Anacor Pharmaceuticals, Inc., Palo Alto, California, United States of America

  ⨯
• Yvonne Freund,

  Affiliation Anacor Pharmaceuticals, Inc., Palo Alto, California, United States of America

  ⨯
• Charles Ding,

  Affiliation Anacor Pharmaceuticals, Inc., Palo Alto, California, United States of America

  ⨯
• Tsutomu Akama,

  Affiliation Anacor Pharmaceuticals, Inc., Palo Alto, California, United States of America

  ⨯
• Y.-K. Zhang,

  Affiliation Anacor Pharmaceuticals, Inc., Palo Alto, California, United States of America

  ⨯
• Reto Brun,

  Affiliation Swiss Tropical and Public Health Institute, Basel, Switzerland

  ⨯
• Marcel Kaiser,

  Affiliation Swiss Tropical and Public Health Institute, Basel, Switzerland

  ⨯
• Ivan Scandale,

  Affiliation Drugs for Neglected Diseases initiative, Geneva, Switzerland

  ⨯
•  [ ... ],
• Robert Don

  Affiliation Drugs for Neglected Diseases initiative, Geneva, Switzerland

  ⨯
• [ view all ]
• [ view less ]